- MLS000069738
- GTPL5155
- MLS001076493
- Tox21_200648
- C01197
- NCGC00022654-07
- CS-0081280
- Q414116
- HMS2235G09
- CHEBI:36281
- NCGC00022654-06
- NCGC00017364-08
- Caffeic acid
- AI3-63211
- InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2
- SR-01000000203-2
- BRD-K09900591-001-25-9
- DB-321780
- Caffeate
- Caffeic acid 1000 microg/mL in Acetone
- 3-(3,4-dihydroxyphenyl)prop-2-enoic acid
- 3-(3,4-Dihydroxyphenyl)-2-propenoic acid
- MLS002222302
- 71693-97-5
- MFCD00004392
- 2-Propenoic acid,4-dihydroxyphenyl)-
- LP00208
- NCGC00017364-07
- AR-360/40806927
- trans-3,4-Dihydroxycinnamic Acid
- SR-01000000203-6
- CHEBI:16433
- HY-N0172
- (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid
- C 0625
- BRD-K09900591-001-26-7
- caffeic acid, (E)-isomer
- CAS-331-39-5
- MLS002207132
- SW197202-3
- 2-Propenoic acid,3-(3,4-dihydroxyphenyl)-, (2E)-
- HMS3260J17
- NCGC00022654-03
- NCGC00017364-04
- NSC-57197
- NCGC00017364-05
- NSC623438
- AS-10895
- NSC-623438
- NCGC00017364-22
- 2-Propenoic acid, 3-(3,4-dihdroxyphenyl)-
- 3-(3,4-Dihydroxy phenyl)-2-propenoic acid
- DB01880
- CS-8205
- Caffeic acid, matrix substance for MALDI-MS, >=99.0% (HPLC)
- SMR000058214
- DTXSID901316055
- NCGC00017364-11
- CAFFEIC ACID [IARC]
- cid_689043
- 3,4-Dihydroxycinnamate, XVII
- DB-318886
- BDBM4375
- CCG-38895
- CAFFEIC ACID [DSC]
- BBL012113
- (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid
- SDCCGSBI-0050196.P004
- (E)-3,4-dihydroxycinnamic acid
- EU-0100208
- NCGC00017364-09
- Caffeic acid, >=98.0% (HPLC)
- CAFFEIC ACID natural
- DTXSID5020231
- (E)-3-(3,4-dihydroxyphenyl)acrylicacid
- 3-(3,4-dihydroxyphenyl)acrylic acid
- SCHEMBL23358
- EN300-1067793
- EINECS 206-361-2
- CAFFEIC ACID [MI]
- caffeic acid
- BCP28271
- trans-Caffeate
- BIDD:ER0456
- 3,4-Dihydroxycinnamic acid
- 3,4-Dihydroxybenzeneacrylate
- trans-Caffeic acid, certified reference material, TraceCERT(R)
- NCGC00017364-13
- STK397812
- NS00010313
- Cinnamic acid,4-dihydroxy-
- XC164210', "4-(2'Carboxyvinyl)-1,2-dihydroxybenzene", 'Caffeic acid, purum, >=95.0% (HPLC)
- BP-30112
- HMS3649O17
- 3,4-Dihydroxycinnamic acid, predominantly trans
- NSC57197
- NCGC00258202-01
- 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-
- 3,4-dihydroxycinnamate
- NCGC00022654-04
- NCGC00017364-06
- Opera_ID_1700
- 331-39-5
- C-1500
- CAFFEIC ACID (CONSTITUENT OF BLACK COHOSH)
- CAFFEIC ACID (IARC)
- (E)-3-(3,4-dihydroxyphenyl)prop-2-enoicacid
- (2E)-3-(3,4-dihydroxyphenyl)acrylic acid
- CAFFEIC ACID [HSDB]
- UNII-U2S3A33KVM', "4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene", '2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)-
- F3096-1708
- SR-01000000203-7
- CHEMBL145
- NCGC00260893-01
- AB00490047
- Caffeic acid, matrix substance for MALDI-MS, >=99.0% (HPLC), powder, light beige
- U2S3A33KVM
- DTXCID10231
- 3,4-dihydroxycinnamic acid (caffeic acid)
- Caffeic acid, United States Pharmacopeia (USP) Reference Standard
- Tox21_500208
- Caffeic acid - Natural
- 3-(3,4-Dihydroxyphenyl)propenoic acid
- AC-8006
- NCGC00022654-05
- SR-01000000203
- NCGC00022654-09
- CAFFEIC ACID [WHO-DD]
- Caffeic Acid - CAS 331-39-5
- SR-01000000203-8
- Caffeic Acid,(S)
- SPECTRUM1503987
- (E)-3-(3,4-dihydroxyphenyl)acrylic acid
- SDCCGMLS-0002982.P003
- 3,4-Dihydroxy-trans-cinnamate
- 3,4-Dihydroxybenzeneacrylic acid
- CCRIS 847
- AKOS000144463
- Cinnamic acid, 3,4-dihydroxy-
- HY-121231
- Caffeic Acid1507
- CAFFEIC ACID (CONSTITUENT OF BLACK COHOSH) [DSC]
- Caffeic acid, 1
- Trans 3,4-Dihydroxycinnamic acid
- NCGC00017364-12
- Caffeic acid pure
- 501-16-6
- caffeic-acid
- C01481
- NCGC00263641-01
- trans-caffeic acid
- 331-89-5
- NCGC00017364-10
- BRD-K09900591-001-06-9
- Caffeicacid
- MLS006011849
- NCGC00022654-08
- SMR004703501
- NSC 57197
- SR-01000000203-13
- 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene
- 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (2E)-
- Z240113804', "2',3-DIHYDROXY-4,4',6'-TRIMETHOXYCHALCONE_met021", "2',4-DIHYDROXY-3,4',6'-TRIMETHOXYCHALCONE_met023", '8B3E4DA7-F3B0-4972-A315-2E387071737F
- Caffeic acid, trans-
- (2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid
- HSDB 7088
- s2277
|
